CC
AVEO

Cannell & Co’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Cannell & Co’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,000
Closed -$12K – 253
2019
Q4 		$12K Hold
2,000
– – ﹤0.01% 238
2019
Q3 		$17K Hold
2,000
– – ﹤0.01% 240
2019
Q2 		$13K Hold
2,000
– – ﹤0.01% 241
2019
Q1 		$16K Sell
2,000
-1,500
-43% -$15.5K ﹤0.01% 247
2018
Q4 		$56K Buy
3,500
+500
+17% +$11K ﹤0.01% 241
2018
Q3 		$99K Hold
3,000
– – ﹤0.01% 246
2018
Q2 		$68K Buy
3,000
+2,000
+200% +$47.4K ﹤0.01% 250
2018
Q1 		$29K Sell
1,000
-9,988
-91% -$292K ﹤0.01% 245
2017
Q4 		$307K Hold
10,988
– – 0.01% 227
2017
Q3 		$401K Hold
10,988
– – 0.01% 211
2017
Q2 		$244K Buy
10,988
+2,050
+23% +$16.1K 0.01% 228
2017
Q1 		$53K Hold
8,938
– – ﹤0.01% 251
2016
Q4 		$48K Sell
8,938
-3,812
-30% -$25.4K ﹤0.01% 246
2016
Q3 		$113K Hold
12,750
– – ﹤0.01% 256
2016
Q2 		$123K Hold
12,750
– – ﹤0.01% 252
2016
Q1 		$117K Hold
12,750
– – ﹤0.01% 250
2015
Q4 		$161K Hold
12,750
– – 0.01% 255
2015
Q3 		$154K Hold
12,750
– – 0.01% 256
2015
Q2 		$222K Buy
12,750
+980
+8% +$17.6K 0.01% 251
2015
Q1 		$171K Hold
11,770
– – 0.01% 256
2014
Q4 		$99K Sell
11,770
-3,270
-22% -$29.9K ﹤0.01% 263
2014
Q3 		$167K Hold
15,040
– – 0.01% 264
2014
Q2 		$275K Hold
15,040
– – 0.01% 242
2014
Q1 		$225K Buy
+15,040
New +$270K 0.01% 252

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cannell & Co's AVEO Position: Q1 2020 in Review

Cannell & Co sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2020, closing a stake of 2,000 shares — an estimated $12K sold.

Cannell & Co first reported a position in AVEO in Q1 2014 and held it in 24 quarters. The position peaked at $401K in Q3 2017. 35 funds tracked by Wall St. Rank hold AVEO as of Q1 2020.

  • Cannell & Co reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Cannell & Co sold 2,000 AVEO Pharmaceuticals, Inc. shares in Q1 2020, an estimated $12K.
  • Cannell & Co first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2014 and held it in 24 quarters.
  • Cannell & Co's AVEO Pharmaceuticals, Inc. position peaked at $401K in Q3 2017.
  • 35 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2020.

Based on Cannell & Co's 13F filing for Q1 2020, filed 5 May 2020.